Synthesis, structural elucidation, and molecular docking of diclofenac-derived hydrazone metal complexes with anti-inflammatory and anticancer potential

A novel Schiff base ligand, (E)-2-(2-((2,6-dichlorophenyl)amino)phenyl)-N'-(2-hydroxynaphthalen-1-yl)methylene)acetohydrazide, was synthesized and complexed with Cu(II), Ni(II), Co(II), Gd(III), La(III), and Ag(I) ions. The resulting metal complexes were characterized using FTIR, UV-Vis, 1H NMR, ESR, XRD, thermal analysis, and magnetic susceptibility measurements. Spectroscopic and magnetic data confirmed octahedral geometries for Co(II), Ni(II), and Cu(II), square antiprismatic and tricapped trigonal prismatic geometries for Gd(III) and La(III), respectively, and a tetrahedral geometry for Ag(I). The anti-inflammatory activity was evaluated using ELISA-based COX-1/COX-2 inhibition assays. The HDN ligand exhibited potent COX-2 inhibition (IC₅₀ = 0.06 µM) with a selectivity index (SI) of 174.5, outperforming diclofenac sodium (SI = 4.52) and indomethacin (SI = 1.25), and approaching rofecoxib (SI = 725). The Cu(II) and Gd(III) complexes showed strong cytotoxicity in MTT assays against MCF-7 (IC₅₀ = 0.65 and 0.80 µM) and HepG-2 (IC₅₀ = 1.00 and 2.47 µM) cell lines, significantly surpassing the HDN ligand and standard drugs such as 5-fluorouracil (IC₅₀ = 3.95 µM, MCF-7) and cisplatin (IC₅₀ = 15.24 µM, MCF-7). In silico studies including molecular docking and ADME profiling supported the experimental findings. The HDN ligand and Cu(II) complex exhibited strong binding affinities to COX-2 (- 22.87 kcal/mol), HepG-2 (- 32.56 and - 31.76 kcal/mol), and MCF-7 (- 25.29 and - 20.20 kcal/mol) receptors. SwissADME and BOILED-Egg models predicted high gastrointestinal absorption for the HDN ligand and favorable pharmacokinetic profiles for the metal complexes. The present results provide a preclinical proof-of-concept for diclofenac-derived Schiff base metal complexes as dual anti-inflammatory and anticancer agents. However, their therapeutic potential remains to be validated through stability, mechanistic, and in vivo investigations.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-11-26
DOI
https://doi.org/10.1038/s41598-025-27143-1
Citations
2
Primary Topic
Metal complexes synthesis and properties
Type
article
Field-Weighted Citation Impact
2.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthesis, structural elucidation, and molecular docking of diclofenac-derived hydrazone metal complexes with anti-inflammatory and anticancer potential

Abbas M. Abbas‎, Hesham A. Salem, Adel S. Orabi
2 citations
Scientific Reports
Metal complexes synthesis and properties
2.09
article

Synthesis, structural elucidation, and molecular docking of diclofenac-derived hydrazone metal complexes with anti-inflammatory and anticancer potential

Abbas M. Abbas‎, Hesham A. Salem, Adel S. Orabi
article en
2 citations

Abstract

A novel Schiff base ligand, (E)-2-(2-((2,6-dichlorophenyl)amino)phenyl)-N'-(2-hydroxynaphthalen-1-yl)methylene)acetohydrazide, was synthesized and complexed with Cu(II), Ni(II), Co(II), Gd(III), La(III), and Ag(I) ions. The resulting metal complexes were characterized using FTIR, UV-Vis, 1H NMR, ESR, XRD, thermal analysis, and magnetic susceptibility measurements. Spectroscopic and magnetic data confirmed octahedral geometries for Co(II), Ni(II), and Cu(II), square antiprismatic and tricapped trigonal prismatic geometries for Gd(III) and La(III), respectively, and a tetrahedral geometry for Ag(I). The anti-inflammatory activity was evaluated using ELISA-based COX-1/COX-2 inhibition assays. The HDN ligand exhibited potent COX-2 inhibition (IC₅₀ = 0.06 µM) with a selectivity index (SI) of 174.5, outperforming diclofenac sodium (SI = 4.52) and indomethacin (SI = 1.25), and approaching rofecoxib (SI = 725). The Cu(II) and Gd(III) complexes showed strong cytotoxicity in MTT assays against MCF-7 (IC₅₀ = 0.65 and 0.80 µM) and HepG-2 (IC₅₀ = 1.00 and 2.47 µM) cell lines, significantly surpassing the HDN ligand and standard drugs such as 5-fluorouracil (IC₅₀ = 3.95 µM, MCF-7) and cisplatin (IC₅₀ = 15.24 µM, MCF-7). In silico studies including molecular docking and ADME profiling supported the experimental findings. The HDN ligand and Cu(II) complex exhibited strong binding affinities to COX-2 (- 22.87 kcal/mol), HepG-2 (- 32.56 and - 31.76 kcal/mol), and MCF-7 (- 25.29 and - 20.20 kcal/mol) receptors. SwissADME and BOILED-Egg models predicted high gastrointestinal absorption for the HDN ligand and favorable pharmacokinetic profiles for the metal complexes. The present results provide a preclinical proof-of-concept for diclofenac-derived Schiff base metal complexes as dual anti-inflammatory and anticancer agents. However, their therapeutic potential remains to be validated through stability, mechanistic, and in vivo investigations.

Scientific ReportsVol. 15(1)
Suez Canal University (EG), Suez University (EG)
Openalex Percentile: Top 10%
Metal complexes synthesis and properties
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.